Minimal Residual Disease in NPM1-Mutated AML
1From the Department of Pediatrics, Division of Hematology, Oncology, Blood and Marrow Transplantation, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee.
The New England Journal of Medicine
|January 21, 2016
Abstract
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.9K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
905
